Leading the way to safer medication
 Crosscheck  Recommender

CEFTAZIDIME Powder for solution for injection (2017)

Active ingredients: Ceftazidime

Product Name and Form

Ceftazidime 1g Powder for solution for injection.

Pharmaceutical form

Powder for solution for injection (Powder for injection).

White to cream coloured, crystalline powder.

Qualitative and Quantitative Composition

Each vial contains ceftazidime 1g (as pentahydrate).

Excipient with known effect: Each gram of ceftazidime contains approximately 52mg (2.26mmol) of sodium.

For the full list of excipients, see section 6.1.

Chemical substance
Description
Ceftazidime

Ceftazidime inhibits bacterial cell wall synthesis following attachment to penicillin binding proteins (PBPs). This results in the interruption of cell wall (peptidoglycan) biosynthesis, which leads to bacterial cell lysis and death.

List of excipients

Sodium carbonate (anhydrous sterile)

Pack sizes and Marketing

Packs of one, five or ten Type II colourless glass 10ml vials stoppered with coated rubber stopper, capped with flip-off cap.

Not all pack sizes may be marketed.

Marketing authorization holder
Authorization dates

Wockhardt UK Ltd, Ash Road North, Wrexham LL13 9UF, UK

15 October 2007

Marketing authorization number:

PL 29831/0031